Zhang, H., Saha, J., Byun, J., Schin, M., Lorenz, M., Kennedy, R. T., . . . Brosius, F. C. (2008). Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. American Physiological Society.
Chicago Style CitationZhang, Hongyu, et al. Rosiglitazone Reduces Renal and Plasma Markers of Oxidative Injury and Reverses Urinary Metabolite Abnormalities in the Amelioration of Diabetic Nephropathy. American Physiological Society, 2008.
Cita MLAZhang, Hongyu, et al. Rosiglitazone Reduces Renal and Plasma Markers of Oxidative Injury and Reverses Urinary Metabolite Abnormalities in the Amelioration of Diabetic Nephropathy. American Physiological Society, 2008.